| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From Wihuri Research Institute (R.O., P.T.K., K.A.L., M.O.P.), Helsinki, Finland, and BioInvent International AB (B.J.), Lund, Sweden.
Correspondence to Petri T. Kovanen, Wihuri Research Institute, Kalliolinnantie 4, FIN-00140 Helsinki, Finland. E-mail petri.kovanen{at}wri.fi
Objective Immune complexes containing oxidatively modified low-density lipoprotein (oxLDL) particles are deposited in human atherosclerotic lesions during atherogenesis. Here we studied whether OxLDLIgG immune complexes (OxLDLIgG ICs) affect survival of human monocytes.
Methods and Results As demonstrated by light microscopy, and analysis of cell proliferation, caspase-3 activity, and DNA fragmentation, OxLDLIgG ICs promoted survival of cultured human monocytes by decreasing their spontaneous apoptosis. OxLDLIgG ICs induced a concentration-dependent production of the major monocyte growth factor, monocyte colony-stimulating factor (M-CSF), by the monocytes, but its inhibition was without effect on OxLDLIgG ICinduced monocyte survival. Rather, OxLDLIgG ICs induced rapid phosphorylation of Akt, suggesting a direct anti-apoptotic effect mediated by cross-linking of Fc
receptors. Experiments with receptor blocking antibodies revealed that the OxLDLIgG ICinduced monocyte survival was mediated by Fc
receptor I.
Conclusions The results show that OxLDLIgG ICs promote survival of monocytes by cross-linking Fc
receptor I and activating Akt-dependent survival signaling. The results reveal a novel mechanism by which an immune reaction toward oxLDL can play a role in the accumulation of macrophages in human atherosclerotic lesions.
Immune complexes containing oxidatively modified low-density lipoprotein (oxLDL) particles are deposited in human atherosclerotic lesions during atherogenesis. Here we show that OxLDLIgG immune complexes (OxLDLIgG ICs) promote the survival of monocytes, independently of produced M-CSF, by cross-linking Fc
receptor I and activating Akt-dependent survival signaling.
Key Words: atherosclerosis monocytes oxLDL
This article has been cited by other articles:
![]() |
M. Lehto, M. I. Mayranpaa, T. Pellinen, P. Ihalmo, S. Lehtonen, P. T. Kovanen, P.-H. Groop, J. Ivaska, and V. M. Olkkonen The R-Ras interaction partner ORP3 regulates cell adhesion J. Cell Sci., March 1, 2008; 121(5): 695 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Namgaladze, A. Kollas, and B. Brune Oxidized LDL attenuates apoptosis in monocytic cells by activating ERK signaling J. Lipid Res., January 1, 2008; 49(1): 58 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hernandez-Vargas, G. Ortiz-Munoz, O. Lopez-Franco, Y. Suzuki, J. Gallego-Delgado, G. Sanjuan, A. Lazaro, V. Lopez-Parra, L. Ortega, J. Egido, et al. Fc{gamma} Receptor Deficiency Confers Protection Against Atherosclerosis in Apolipoprotein E Knockout Mice Circ. Res., November 24, 2006; 99(11): 1188 - 1196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Saad, G. Virella, C. Chassereau, R. J. Boackle, and M. F. Lopes-Virella OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages J. Lipid Res., September 1, 2006; 47(9): 1975 - 1983. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |